Antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Ireland

6Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Between January 1999 and June 2002, 646 invasive isolates of Streptococcus pneumoniae were collected in Ireland. MICs of penicillin, ciprofloxacin, cefotaxime, moxifloxacin and linezolid were determined by Etest methodology. Eighty-seven (13.5%) isolates showed intermediate resistance to penicillin, while seven (1.1%) showed high-level resistance. Eighty-seven (13.5%) isolates were resistant to erythromycin, but all isolates were susceptible to cefotaxime, moxifloxacin and linezolid. The prevalence of pneumococcal isolates non-susceptible to penicillin in Ireland is worryingly high, but currently there are alternative agents available to treat invasive infection. © 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases.

Cite

CITATION STYLE

APA

Clarke, P., Murchan, S., Smyth, E. G., & Humphreys, H. (2004). Antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Ireland. Clinical Microbiology and Infection, 10(7), 657–659. https://doi.org/10.1111/j.1469-0691.2004.00894.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free